Abstract
β-Haloalkylamine derivatives such as phenoxybenzamine are thought to irreversibly inactivate noradrenaline receptors by a process involving the formation of a reactive ethyleneimmonium cation which is followed by ring scission yielding the reactive carbonium ion which can then react further with a nucleophilic centre located on the receptor. Further study of catecholamine function has awaited the development of similar agents which can alkylate the dopamine receptor. We report here on the structure (Fig. 1) and evaluation of one agent with such potential, (−)N-(chloroethyl)norapomorphine [(−)NCA], and that this compound may be of significant value as a pharmacological and biochemical probe of the dopamine receptor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ungerstedt, U. Acta physiol. scand. Suppl. 367, 49–68 (1971).
Costall, B., Marsden, C. D., Naylor, R. J. & Pycock, C. J. Brain Res. 118, 87–113 (1976).
Titeler, M. & Seeman, P. Eur. J. Pharmac. 56, 291–292 (1979).
Creese, I., Padgett, L., Fazzini, E. & Lopez, F. Eur. J. Pharmac. 56, 411–412 (1979).
Quik, M. & Iversen, L. L. Naunyn-Schmiedeberg's Arch. Pharmac. 304, 141–145 (1978).
Seeman, P., Woodruff, G. N. & Poat, J. A. Eur. J. Pharmac. 55, 137–142 (1979).
Fuxe, K., Hall, H. & Kohler, C. Eur. J. Pharmac. 58, 515–517 (1979).
Law, S.-J., Neumeyer, J. L., Kula, N. & Baldessarini, R. J. J. med. Chem. (in the press).
Costall, B., Fortune, D. H., Naylor, R. J. & Nohria, V. Eur. J. Pharmac. 56, 207–216 (1979).
Costall, B., Naylor, R. J. & Pinder, R. M. J. Pharm. Pharmac. 26, 753–762 (1974).
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. J. biol. Chem. 193, 265–275 (1951).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Costall, B., Fortune, D., Law, SJ. et al. (−)N-(Chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor binding. Nature 285, 571–573 (1980). https://doi.org/10.1038/285571a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/285571a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.